LEADER 01724nam  2200457   450 
001 9910703262203321
005 20221105091422.0
035   $a(CKB)3450000000002443
035   $a(NjHacI)993450000000002443
035   $a(OCoLC)755702762
035   $a(OCoLC)993450000000002443
035   $a(EXLCZ)993450000000002443
100   $a20221105d2010      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLactose intolerance and health /$fTimothy J. Wilt [and ten others]
210  1$aRockville, Maryland :$cAgency for Healthcare Research and Quality (US),$d[2010]
210  4$dİ2010
215   $a1 online resource (x, 157 pages) $cillustrations
225 1 $aEvidence report/technology assessment ;$vNumber 192
300   $aTitle from title screen (viewed on January 18, 2012).
300   $a"This report is based on research conducted by the Minnesota Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD."
300   $a"February 2010."
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vNumber 192.
606   $aLactose intolerance
615  0$aLactose intolerance.
676   $a616.3
700   $aWilt$b Timothy J.$01353022
701   $aWilt$b Timothy J$00
712 02$aMinnesota Evidence-based Practice Center.
712 02$aUnited States.$bAgency for Healthcare Research and Quality,
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910703262203321
996   $aLactose intolerance and health$93215711
997   $aUNINA